[ Price : $8.95]
FDA removes a partial clinical hold against Salarius Pharmaceuticals and its Phase 1/2 clinical trial evaluating seclidemstat in p...[ Price : $8.95]
FDA medical reviewers ask the FDA Pulmonary-Allergy Drug Advisory Committee to consider the adequacy of pharmacokinetic and pharma...[ Price : $8.95]
FDA removes a clinical hold against two Immuron trials of Travelan, an orally administered passive immunotherapy that prophylactic...[ Price : $8.95]
FDA grants Singlera Genomics a breakthrough device designation for its PDACatch assay, a DNA methylation-based liquid biopsy assay...[ Price : $8.95]
FDA approves Eyenovias Mydcombi (tropicamide and phenylephrine HCl ophthalmic spray) for inducing mydriasis for diagnostic procedu...[ Price : $8.95]
FDA announces a 5/11-12 workshop entitled Fiscal Year 2023 Generic Drug Science and Research Initiatives Public Workshop.[ Price : $8.95]
FDA clears a Samsung Electronics 510(k) for its Irregular Heart Rhythm Notification feature on its Health Monitor app for Samsung ...[ Price : $8.95]
FDA grants Ortho-Clinical Diagnostics two de novo marketing authorizations for its Vitros Covid-19 serology tests.